speb/financial-data huggingface dataset:
NYAX income_statement (annual, 2025-12-31) — Pretax Income: 34566000.00
NYAX income_statement (quarterly, 2025-12-31) — Pretax Income: 10610000.00
NYAX cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 4945000.00
NYAX cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 878000.00
NYAX balance_sheet (annual, 2025-12-31) — Properties: 0.00
NYAX balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
NYAX income_statement (annual, 2025-12-31) — Provision For Doubtful Accounts: 1748000.00
NYAX cash_flow (annual, 2025-12-31) — Purchase Of Business: -51940000.00
NYAX cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -28112000.00
NYAX cash_flow (annual, 2025-12-31) — Purchase Of Investment: -6416000.00
NYAX cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -1416000.00
NYAX cash_flow (annual, 2025-12-31) — Purchase Of PPE: -5329000.00
NYAX cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -1352000.00
NYAX balance_sheet (annual, 2025-12-31) — Receivables: 151840000.00
NYAX balance_sheet (quarterly, 2025-12-31) — Receivables: 151840000.00
NYAX income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 204810000.00
NYAX income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 69405000.00
NYAX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 25487000.00
NYAX income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 6922000.00
NYAX cash_flow (annual, 2025-12-31) — Repayment Of Debt: -12739000.00
NYAX cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -2655000.00
NYAX income_statement (annual, 2025-12-31) — Research And Development: 29959000.00
NYAX income_statement (quarterly, 2025-12-31) — Research And Development: 6254000.00
NYAX balance_sheet (annual, 2025-12-31) — Restricted Cash: 91965000.00
NYAX balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 91965000.00
NYAX balance_sheet (annual, 2025-12-31) — Retained Earnings: -19635000.00
NYAX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -19635000.00
NYAX income_statement (annual, 2025-12-31) — Salaries And Wages: 65586000.00
NYAX cash_flow (annual, 2025-12-31) — Sale Of Investment: 11122000.00
NYAX cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 6196000.00
NYAX income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 5246000.00
NYAX income_statement (annual, 2025-12-31) — Selling General And Administration: 95618000.00
NYAX income_statement (quarterly, 2025-12-31) — Selling General And Administration: 6852000.00
NYAX balance_sheet (annual, 2025-12-31) — Share Issued: 37301367.00
NYAX balance_sheet (quarterly, 2025-12-31) — Share Issued: 37301367.00
NYAX cash_flow (annual, 2025-12-31) — Stock Based Compensation: 7305000.00
NYAX cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 448000.00
NYAX balance_sheet (annual, 2025-12-31) — Stockholders Equity: 231015000.00
NYAX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 231015000.00
NYAX balance_sheet (annual, 2025-12-31) — Tangible Book Value: 40522000.00
NYAX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 40522000.00
NYAX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 960940.00
NYAX income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
NYAX income_statement (annual, 2025-12-31) — Tax Provision: -950000.00
NYAX income_statement (quarterly, 2025-12-31) — Tax Provision: -2561000.00
NYAX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.23
NYAX income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.23
NYAX balance_sheet (annual, 2025-12-31) — Total Assets: 852638000.00
NYAX balance_sheet (quarterly, 2025-12-31) — Total Assets: 852638000.00
NYAX balance_sheet (annual, 2025-12-31) — Total Capitalization: 555544000.00
NYAX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 555544000.00
NYAX balance_sheet (annual, 2025-12-31) — Total Debt: 337625000.00
NYAX balance_sheet (quarterly, 2025-12-31) — Total Debt: 337625000.00
NYAX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 231015000.00
NYAX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 231015000.00
NYAX income_statement (annual, 2025-12-31) — Total Expenses: 362647000.00
NYAX income_statement (quarterly, 2025-12-31) — Total Expenses: 107150000.00
NYAX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 621623000.00
NYAX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 621623000.00
NYAX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 232474000.00
NYAX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 232474000.00
NYAX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 347205000.00
NYAX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 347205000.00
NYAX income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 37560000.00
NYAX income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 12304000.00
NYAX income_statement (annual, 2025-12-31) — Total Other Finance Cost: 773000.00
NYAX income_statement (annual, 2025-12-31) — Total Unusual Items: 4178000.00
NYAX income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 4178000.00
NYAX balance_sheet (annual, 2025-12-31) — Working Capital: 345746000.00
NYAX balance_sheet (quarterly, 2025-12-31) — Working Capital: 345746000.00
NYAX income_statement (quarterly, 2026-03-31) — +Operating Expense: 48141000.00
NYAX income_statement (quarterly, 2026-03-31) — +Total Revenue: 106856000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 22242000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 100558000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 243877000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 213000.00
NYAX income_statement (quarterly, 2026-03-31) — Basic Average Shares: 37355838.00
NYAX income_statement (quarterly, 2026-03-31) — Basic EPS: 0.03
NYAX cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 319538000.00
NYAX cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -9598000.00
NYAX cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -7794000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 8922000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Capital Stock: 9000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 304745000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 306237000.00
NYAX cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: 0.00
NYAX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -10160000.00
NYAX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -9591000.00
NYAX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 3578000.00
NYAX cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -7325000.00
NYAX cash_flow (quarterly, 2026-03-31) — Change In Inventory: 70000.00
NYAX cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -2351000.00
NYAX cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -6171000.00
NYAX cash_flow (quarterly, 2026-03-31) — Change In Payable: 20934000.00
NYAX cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 20934000.00
NYAX cash_flow (quarterly, 2026-03-31) — Change In Receivables: -21923000.00
NYAX cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -9441000.00
NYAX cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 3332000.00
NYAX cash_flow (quarterly, 2026-03-31) — Changes In Cash: -16173000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Common Stock: 9000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 235376000.00
NYAX income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 54582000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Current Assets: 634678000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 3401000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Current Debt: 3220000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 6621000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 295492000.00
NYAX cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -1224000.00
NYAX cash_flow (quarterly, 2026-03-31) — Deferred Tax: -1224000.00
NYAX cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 7177000.00
NYAX income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 3825000.00
NYAX cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 7177000.00
NYAX income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 3825000.00
NYAX income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 41546785.00
NYAX income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.03
NYAX income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1280000.00
NYAX income_statement (quarterly, 2026-03-31) — EBIT: 7088000.00
NYAX income_statement (quarterly, 2026-03-31) — EBITDA: 14265000.00
NYAX income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: 0.00
NYAX cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: 0.00
NYAX cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 1380000.00
NYAX cash_flow (quarterly, 2026-03-31) — End Cash Position: 304745000.00
NYAX cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -10160000.00
NYAX cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -6020000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 7446000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 193662000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 100558000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Gross PPE: 29655000.00
NYAX income_statement (quarterly, 2026-03-31) — Gross Profit: 52274000.00
NYAX income_statement (quarterly, 2026-03-31) — Interest Expense: 6361000.00
NYAX income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 6361000.00
NYAX income_statement (quarterly, 2026-03-31) — Interest Income: 2955000.00
NYAX income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 2955000.00
NYAX cash_flow (quarterly, 2026-03-31) — Interest Paid Cff: -9775000.00
NYAX cash_flow (quarterly, 2026-03-31) — Interest Received Cfi: 2816000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Inventory: 28552000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Invested Capital: 560719000.00
NYAX cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -9591000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 213000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 213000.00
NYAX cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 0.00
NYAX balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 5521000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 322123000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 327644000.00
NYAX cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 0.00
NYAX cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -1729000.00
NYAX cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -2768000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Net Debt: 20598000.00
NYAX income_statement (quarterly, 2026-03-31) — Net Income: 1280000.00
NYAX income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 1280000.00
NYAX income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 1280000.00
NYAX income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1280000.00
NYAX income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1280000.00
NYAX cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 1280000.00
NYAX income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 1280000.00
NYAX income_statement (quarterly, 2026-03-31) — Net Interest Income: -3406000.00
NYAX cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -270000.00
NYAX cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -1729000.00
NYAX cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -1729000.00
NYAX income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -3406000.00
NYAX cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 229000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Net PPE: 29655000.00
NYAX cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -1804000.00
NYAX cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 0.00
NYAX balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 41714000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 4860000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 6785000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 4860000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 6785000.00
NYAX income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 14265000.00
NYAX income_statement (quarterly, 2026-03-31) — Normalized Income: 1280000.00
NYAX cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 3578000.00
NYAX cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 9000.00
NYAX income_statement (quarterly, 2026-03-31) — Operating Income: 4133000.00
NYAX income_statement (quarterly, 2026-03-31) — Operating Revenue: 106856000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 37301367.00
NYAX balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 28075000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 3220000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 5542000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 7446000.00
NYAX cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 3525000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 8740000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 6511000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Other Payable: 261087000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Other Properties: 29655000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Other Receivables: 73120000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 1492000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Payables: 283329000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 283329000.00
NYAX cash_flow (quarterly, 2026-03-31) — Pension And Employee Benefit Expense: 9000.00
NYAX income_statement (quarterly, 2026-03-31) — Pretax Income: 727000.00
NYAX cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 1344000.00
NYAX cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -2768000.00
NYAX cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -270000.00
NYAX cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -1804000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Receivables: 173678000.00
NYAX income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 51230000.00
NYAX income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 7177000.00
NYAX cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -1729000.00
NYAX income_statement (quarterly, 2026-03-31) — Research And Development: 7996000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 98136000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -15956000.00
NYAX cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 0.00
NYAX income_statement (quarterly, 2026-03-31) — Selling General And Administration: 36320000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Share Issued: 37301367.00
NYAX cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 2252000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 235376000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 41714000.00
NYAX income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
NYAX income_statement (quarterly, 2026-03-31) — Tax Provision: -553000.00
NYAX income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
NYAX balance_sheet (quarterly, 2026-03-31) — Total Assets: 871808000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 557499000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Total Debt: 334265000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 235376000.00
NYAX income_statement (quarterly, 2026-03-31) — Total Expenses: 102723000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 636432000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 237130000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 340940000.00
NYAX income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 4133000.00
NYAX balance_sheet (quarterly, 2026-03-31) — Working Capital: 339186000.00
NYC balance_sheet (annual, 2021-12-31) — Accounts Payable: 8131000.00
NYC cash_flow (annual, 2021-12-31) — Cash Dividends Paid: -5201000.00
NYC cash_flow (annual, 2021-12-31) — Common Stock Dividend Paid: -5201000.00
NYC balance_sheet (annual, 2021-12-31) — Derivative Product Liabilities: 1553000.00
NYC balance_sheet (annual, 2021-12-31) — Financial Assets: 0.00
NYC cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -160000.00
NYC balance_sheet (annual, 2021-12-31) — Other Current Assets: 9293000.00
NYC balance_sheet (annual, 2021-12-31) — Other Equity Adjustments: -1553000.00
NYC balance_sheet (annual, 2021-12-31) — Other Intangible Assets: 87478000.00
NYC balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 4224000.00
NYC balance_sheet (annual, 2021-12-31) — Other Properties: 55167000.00
NYC balance_sheet (annual, 2021-12-31) — Other Receivables: 25838000.00
NYC balance_sheet (annual, 2021-12-31) — Payables: 8131000.00
NYC balance_sheet (annual, 2021-12-31) — Prepaid Assets: 9293000.00
NYC cash_flow (annual, 2021-12-31) — Purchase Of Investment Properties: 0.00
NYC income_statement (annual, 2021-12-31) — Restructuring And Mergern Acquisition: 0.00
NYC income_statement (annual, 2022-12-31) — +Operating Expense: 49941000.00
NYC income_statement (annual, 2022-12-31) — +Total Revenue: 64005000.00
NYC balance_sheet (annual, 2022-12-31) — Accounts Receivable: 29116000.00
NYC balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 698761000.00
NYC cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
NYC income_statement (annual, 2022-12-31) — Basic Average Shares: 1729264.00
NYC income_statement (annual, 2022-12-31) — Basic EPS: -26.59
NYC cash_flow (annual, 2022-12-31) — Beginning Cash Position: 28428000.00
NYC cash_flow (annual, 2022-12-31) — Capital Expenditure: -5555000.00
NYC cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -5555000.00
NYC balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 57722000.00
NYC balance_sheet (annual, 2022-12-31) — Capital Stock: 19000.00
NYC balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 9215000.00
NYC balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 9215000.00
NYC cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -2670000.00
NYC cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -6270000.00
NYC cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -5555000.00
NYC cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -486000.00
NYC cash_flow (annual, 2022-12-31) — Change In Account Payable: 110000.00
NYC cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -909000.00
NYC cash_flow (annual, 2022-12-31) — Change In Payable: 110000.00
NYC cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 4045000.00
NYC cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 1490000.00
NYC cash_flow (annual, 2022-12-31) — Change In Receivables: -3274000.00
NYC cash_flow (annual, 2022-12-31) — Change In Working Capital: 1352000.00
NYC cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -3274000.00
NYC cash_flow (annual, 2022-12-31) — Changes In Cash: -12311000.00
NYC balance_sheet (annual, 2022-12-31) — Common Stock: 19000.00
NYC cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -2670000.00
NYC balance_sheet (annual, 2022-12-31) — Common Stock Equity: 301062000.00
NYC cash_flow (annual, 2022-12-31) — Common Stock Issuance: 1980000.00
NYC cash_flow (annual, 2022-12-31) — Common Stock Payments: 0.00
NYC income_statement (annual, 2022-12-31) — Cost Of Revenue: 41009000.00
NYC balance_sheet (annual, 2022-12-31) — Current Assets: 45233000.00
NYC balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 4211000.00
NYC balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 4211000.00
NYC balance_sheet (annual, 2022-12-31) — Current Liabilities: 16998000.00
NYC cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 28666000.00
NYC income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 28666000.00
NYC cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 28666000.00
NYC income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 28666000.00
NYC balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 0.00
NYC income_statement (annual, 2022-12-31) — Diluted Average Shares: 1729264.00
NYC income_statement (annual, 2022-12-31) — Diluted EPS: -26.59
NYC income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -45976000.00
NYC income_statement (annual, 2022-12-31) — EBIT: -26972000.00
NYC income_statement (annual, 2022-12-31) — EBITDA: 1694000.00
NYC cash_flow (annual, 2022-12-31) — End Cash Position: 16117000.00
NYC balance_sheet (annual, 2022-12-31) — Financial Assets: 1607000.00
NYC cash_flow (annual, 2022-12-31) — Financing Cash Flow: -6270000.00
NYC cash_flow (annual, 2022-12-31) — Free Cash Flow: -6041000.00
NYC cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 0.00
NYC balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 1637000.00
NYC income_statement (annual, 2022-12-31) — General And Administrative Expense: 21275000.00
NYC balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 35337000.00
NYC balance_sheet (annual, 2022-12-31) — Gross PPE: 54954000.00
NYC income_statement (annual, 2022-12-31) — Gross Profit: 22996000.00
NYC income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
NYC income_statement (annual, 2022-12-31) — Interest Expense: 18924000.00
NYC income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 18924000.00
NYC cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 17396000.00
NYC balance_sheet (annual, 2022-12-31) — Invested Capital: 695221000.00
NYC cash_flow (annual, 2022-12-31) — Investing Cash Flow: -5555000.00
NYC balance_sheet (annual, 2022-12-31) — Investment Properties: 637819000.00
NYC cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 1980000.00
NYC cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
NYC balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 57722000.00
NYC balance_sheet (annual, 2022-12-31) — Long Term Debt: 394159000.00
NYC balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 451881000.00
NYC cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
NYC cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -5500000.00
NYC balance_sheet (annual, 2022-12-31) — Minority Interest: 20514000.00
NYC cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 1980000.00
NYC balance_sheet (annual, 2022-12-31) — Net Debt: 384944000.00
NYC income_statement (annual, 2022-12-31) — Net Income: -45896000.00
NYC income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -45976000.00
NYC income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -45896000.00
NYC income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -45896000.00
NYC income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -45896000.00
NYC cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -45896000.00
NYC income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -45896000.00
NYC income_statement (annual, 2022-12-31) — Net Interest Income: -18924000.00
NYC cash_flow (annual, 2022-12-31) — Net Investment Properties Purchase And Sale: 0.00
NYC cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -5500000.00
NYC cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -5500000.00
NYC income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -18924000.00
NYC cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -80000.00
NYC balance_sheet (annual, 2022-12-31) — Net PPE: 54954000.00
NYC balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 265725000.00
NYC balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 9881000.00
NYC income_statement (annual, 2022-12-31) — Normalized EBITDA: 1694000.00
NYC income_statement (annual, 2022-12-31) — Normalized Income: -45896000.00
NYC cash_flow (annual, 2022-12-31) — Operating Cash Flow: -486000.00
NYC income_statement (annual, 2022-12-31) — Operating Income: -26945000.00
NYC income_statement (annual, 2022-12-31) — Operating Revenue: 64005000.00
NYC balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 1886298.00
NYC balance_sheet (annual, 2022-12-31) — Other Current Assets: 5624000.00
NYC balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 1637000.00
NYC income_statement (annual, 2022-12-31) — Other Gand A: 12493000.00
NYC income_statement (annual, 2022-12-31) — Other Income Expense: -27000.00
NYC balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 71848000.00
NYC cash_flow (annual, 2022-12-31) — Other Non Cash Items: 6610000.00
NYC balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 5624000.00
NYC balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 3006000.00
NYC income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -27000.00
NYC balance_sheet (annual, 2022-12-31) — Other Properties: 54954000.00
NYC income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 80000.00
NYC balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 12787000.00
NYC balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
NYC income_statement (annual, 2022-12-31) — Pretax Income: -45896000.00
NYC balance_sheet (annual, 2022-12-31) — Receivables: 29116000.00
NYC income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 41009000.00
NYC income_statement (annual, 2022-12-31) — Reconciled Depreciation: 28666000.00
NYC cash_flow (annual, 2022-12-31) — Repayment Of Debt: -5500000.00
NYC cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: 0.00
NYC balance_sheet (annual, 2022-12-31) — Restricted Cash: 6902000.00
NYC balance_sheet (annual, 2022-12-31) — Retained Earnings: -399355000.00
NYC income_statement (annual, 2022-12-31) — Salaries And Wages: 8782000.00
NYC cash_flow (annual, 2022-12-31) — Sale Of Investment Properties: 0.00
NYC income_statement (annual, 2022-12-31) — Selling General And Administration: 21275000.00
NYC balance_sheet (annual, 2022-12-31) — Share Issued: 1886298.00
NYC income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
NYC cash_flow (annual, 2022-12-31) — Stock Based Compensation: 8782000.00
NYC balance_sheet (annual, 2022-12-31) — Stockholders Equity: 301062000.00
NYC balance_sheet (annual, 2022-12-31) — Tangible Book Value: 265725000.00
NYC income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
NYC income_statement (annual, 2022-12-31) — Tax Provision: 0.00
NYC income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
NYC balance_sheet (annual, 2022-12-31) — Total Assets: 790455000.00
NYC balance_sheet (annual, 2022-12-31) — Total Capitalization: 695221000.00
NYC balance_sheet (annual, 2022-12-31) — Total Debt: 451881000.00
NYC balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 321576000.00
NYC income_statement (annual, 2022-12-31) — Total Expenses: 90950000.00
NYC balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 468879000.00
NYC balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 745222000.00
NYC balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 451881000.00
NYC income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -26945000.00
NYC income_statement (annual, 2022-12-31) — Total Unusual Items: 0.00
NYC income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 0.00
NYC balance_sheet (annual, 2022-12-31) — Working Capital: 28235000.00
NYC income_statement (annual, 2023-12-31) — +Operating Expense: 41770000.00
NYC income_statement (annual, 2023-12-31) — +Total Revenue: 62710000.00
NYC balance_sheet (annual, 2023-12-31) — Accounts Payable: 12955000.00
NYC balance_sheet (annual, 2023-12-31) — Accounts Receivable: 30752000.00
NYC balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 729644000.00
NYC cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 66565000.00
NYC income_statement (annual, 2023-12-31) — Basic Average Shares: 2226721.00
NYC income_statement (annual, 2023-12-31) — Basic EPS: -47.57
NYC cash_flow (annual, 2023-12-31) — Beginning Cash Position: 16117000.00
NYC cash_flow (annual, 2023-12-31) — Capital Expenditure: -4059000.00
NYC cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -4059000.00
NYC balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 56718000.00
NYC balance_sheet (annual, 2023-12-31) — Capital Stock: 23000.00
NYC balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 5292000.00
NYC balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 5292000.00
NYC cash_flow (annual, 2023-12-31) — Cash Dividends Paid: 0.00
NYC cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 4025000.00
NYC cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 71000.00
NYC cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -7405000.00
NYC cash_flow (annual, 2023-12-31) — Change In Account Payable: 980000.00
NYC cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -228000.00
NYC cash_flow (annual, 2023-12-31) — Change In Payable: 980000.00
NYC cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 980000.00
NYC cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -1516000.00
NYC cash_flow (annual, 2023-12-31) — Change In Receivables: -1635000.00
NYC cash_flow (annual, 2023-12-31) — Change In Working Capital: -2399000.00
NYC cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -1635000.00
NYC cash_flow (annual, 2023-12-31) — Changes In Cash: -3309000.00
NYC balance_sheet (annual, 2023-12-31) — Common Stock: 23000.00
NYC cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: 0.00
NYC balance_sheet (annual, 2023-12-31) — Common Stock Equity: 224794000.00
NYC cash_flow (annual, 2023-12-31) — Common Stock Issuance: 4059000.00
NYC cash_flow (annual, 2023-12-31) — Common Stock Payments: -24000.00
NYC income_statement (annual, 2023-12-31) — Cost Of Revenue: 41477000.00
NYC balance_sheet (annual, 2023-12-31) — Current Assets: 43560000.00
NYC balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 3983000.00
NYC balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 3983000.00
NYC balance_sheet (annual, 2023-12-31) — Current Liabilities: 16958000.00
NYC cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 26532000.00
NYC income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 26532000.00
NYC cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 26532000.00
NYC income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 26532000.00
NYC income_statement (annual, 2023-12-31) — Diluted Average Shares: 2226721.00
NYC income_statement (annual, 2023-12-31) — Diluted EPS: -47.57
NYC income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -105924000.00
NYC balance_sheet (annual, 2023-12-31) — Dueto Related Parties Current: 20000.00
NYC income_statement (annual, 2023-12-31) — EBIT: -87066000.00
NYC income_statement (annual, 2023-12-31) — EBITDA: -60534000.00
NYC cash_flow (annual, 2023-12-31) — End Cash Position: 12808000.00
NYC balance_sheet (annual, 2023-12-31) — Financial Assets: 400000.00
NYC cash_flow (annual, 2023-12-31) — Financing Cash Flow: 4025000.00
NYC cash_flow (annual, 2023-12-31) — Free Cash Flow: -11464000.00
NYC cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 0.00
NYC balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 406000.00
NYC income_statement (annual, 2023-12-31) — General And Administrative Expense: 15238000.00
NYC balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 30225000.00
NYC balance_sheet (annual, 2023-12-31) — Gross PPE: 54737000.00
NYC income_statement (annual, 2023-12-31) — Gross Profit: 21233000.00
NYC income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 66565000.00
NYC cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 0.00
NYC income_statement (annual, 2023-12-31) — Interest Expense: 18858000.00
NYC income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 18858000.00
NYC cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 17277000.00
NYC balance_sheet (annual, 2023-12-31) — Invested Capital: 620496000.00
NYC cash_flow (annual, 2023-12-31) — Investing Cash Flow: 71000.00
NYC balance_sheet (annual, 2023-12-31) — Investment Properties: 549948000.00
NYC cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 4059000.00
NYC cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
NYC balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 56718000.00
NYC balance_sheet (annual, 2023-12-31) — Long Term Debt: 395702000.00
NYC balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 452420000.00
NYC cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
NYC cash_flow (annual, 2023-12-31) — Long Term Debt Payments: 0.00
NYC balance_sheet (annual, 2023-12-31) — Minority Interest: 0.00
NYC cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 4035000.00
NYC balance_sheet (annual, 2023-12-31) — Net Debt: 390410000.00
NYC income_statement (annual, 2023-12-31) — Net Income: -105924000.00
NYC income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -105924000.00
NYC income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -105924000.00
NYC income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -105924000.00
NYC income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -105924000.00
NYC cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -105924000.00
NYC income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -105924000.00
NYC income_statement (annual, 2023-12-31) — Net Interest Income: -18858000.00
NYC cash_flow (annual, 2023-12-31) — Net Investment Properties Purchase And Sale: 4130000.00
NYC cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 0.00
NYC cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 0.00
NYC income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -18858000.00
NYC cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -10000.00
NYC balance_sheet (annual, 2023-12-31) — Net PPE: 54737000.00
NYC balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 194569000.00
NYC balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 9152000.00
NYC income_statement (annual, 2023-12-31) — Normalized EBITDA: 6031000.00
NYC income_statement (annual, 2023-12-31) — Normalized Income: -39359000.00
NYC cash_flow (annual, 2023-12-31) — Operating Cash Flow: -7405000.00
NYC income_statement (annual, 2023-12-31) — Operating Income: -20537000.00
NYC income_statement (annual, 2023-12-31) — Operating Revenue: 62710000.00
NYC balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 2334340.00
NYC balance_sheet (annual, 2023-12-31) — Other Current Assets: 6150000.00
NYC balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 406000.00
NYC income_statement (annual, 2023-12-31) — Other Gand A: 9375000.00
NYC income_statement (annual, 2023-12-31) — Other Income Expense: -66529000.00
NYC cash_flow (annual, 2023-12-31) — Other Non Cash Items: 1958000.00
NYC balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 6150000.00
NYC balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 2061000.00
NYC income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 36000.00
NYC balance_sheet (annual, 2023-12-31) — Other Properties: 54737000.00
NYC income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
NYC balance_sheet (annual, 2023-12-31) — Payables: 12975000.00
NYC balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 12975000.00
NYC balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
NYC income_statement (annual, 2023-12-31) — Pretax Income: -105924000.00
NYC balance_sheet (annual, 2023-12-31) — Receivables: 30752000.00
NYC income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 41477000.00
NYC income_statement (annual, 2023-12-31) — Reconciled Depreciation: 26532000.00
NYC cash_flow (annual, 2023-12-31) — Repayment Of Debt: 0.00
NYC cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -24000.00
NYC balance_sheet (annual, 2023-12-31) — Restricted Cash: 7516000.00
NYC balance_sheet (annual, 2023-12-31) — Retained Earnings: -505279000.00
NYC income_statement (annual, 2023-12-31) — Salaries And Wages: 5863000.00
NYC cash_flow (annual, 2023-12-31) — Sale Of Investment Properties: 4130000.00
NYC income_statement (annual, 2023-12-31) — Selling General And Administration: 15238000.00
NYC balance_sheet (annual, 2023-12-31) — Share Issued: 2334340.00
NYC income_statement (annual, 2023-12-31) — Special Income Charges: -66565000.00
NYC cash_flow (annual, 2023-12-31) — Stock Based Compensation: 5863000.00
NYC balance_sheet (annual, 2023-12-31) — Stockholders Equity: 224794000.00
NYC balance_sheet (annual, 2023-12-31) — Tangible Book Value: 194569000.00
NYC income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
NYC income_statement (annual, 2023-12-31) — Tax Provision: 0.00
NYC income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
NYC balance_sheet (annual, 2023-12-31) — Total Assets: 694172000.00
NYC balance_sheet (annual, 2023-12-31) — Total Capitalization: 620496000.00
NYC balance_sheet (annual, 2023-12-31) — Total Debt: 452420000.00
NYC balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 224794000.00
NYC income_statement (annual, 2023-12-31) — Total Expenses: 83247000.00
NYC balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 469378000.00
NYC balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 650612000.00
NYC balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 452420000.00
NYC income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -87102000.00
NYC income_statement (annual, 2023-12-31) — Total Unusual Items: -66565000.00
NYC income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -66565000.00
NYC balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
NYC balance_sheet (annual, 2023-12-31) — Working Capital: 26602000.00
NYC cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: 27817000.00
NYC balance_sheet (quarterly, 2024-09-30) — Assets Held For Sale Current: 52924000.00
NYC cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 0.00
NYC cash_flow (quarterly, 2024-09-30) — Common Stock Payments: 0.00
NYC balance_sheet (quarterly, 2024-09-30) — Financial Assets: 0.00
NYC income_statement (quarterly, 2024-09-30) — Impairment Of Capital Assets: 27817000.00
NYC cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 0.00
NYC cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 0.00
NYC balance_sheet (quarterly, 2024-09-30) — Other Properties: 54570000.00
NYC cash_flow (quarterly, 2024-09-30) — Repurchase Of Capital Stock: 0.00
NYC income_statement (quarterly, 2024-09-30) — Special Income Charges: -27817000.00
NYC income_statement (annual, 2024-12-31) — +Operating Expense: 28032000.00
NYC income_statement (annual, 2024-12-31) — +Total Revenue: 61570000.00
NYC balance_sheet (annual, 2024-12-31) — Accounts Payable: 14985000.00
NYC balance_sheet (annual, 2024-12-31) — Accounts Receivable: 23060000.00
NYC balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 731429000.00
NYC cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 112541000.00
NYC cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 0.00
NYC income_statement (annual, 2024-12-31) — Basic Average Shares: 2487827.00
NYC income_statement (annual, 2024-12-31) — Basic EPS: -56.51
NYC cash_flow (annual, 2024-12-31) — Beginning Cash Position: 12808000.00
NYC cash_flow (annual, 2024-12-31) — Capital Expenditure: -1291000.00
NYC cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -1291000.00
NYC balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 55753000.00
NYC balance_sheet (annual, 2024-12-31) — Capital Stock: 27000.00
NYC balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 9776000.00
NYC balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 9776000.00
NYC cash_flow (annual, 2024-12-31) — Cash Dividends Paid: 0.00
NYC cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -49731000.00
NYC cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 59857000.00
NYC cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -3999000.00
NYC cash_flow (annual, 2024-12-31) — Change In Account Payable: 2478000.00
NYC cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -942000.00
NYC cash_flow (annual, 2024-12-31) — Change In Payable: 2478000.00
NYC cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 2478000.00
NYC cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 238000.00
NYC cash_flow (annual, 2024-12-31) — Change In Receivables: 869000.00
NYC cash_flow (annual, 2024-12-31) — Change In Working Capital: 2643000.00
NYC cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 869000.00
NYC cash_flow (annual, 2024-12-31) — Changes In Cash: 6127000.00
NYC balance_sheet (annual, 2024-12-31) — Common Stock: 27000.00
NYC cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: 0.00
NYC balance_sheet (annual, 2024-12-31) — Common Stock Equity: 85586000.00
NYC cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
NYC cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
NYC cash_flow (annual, 2024-12-31) — Common Stock Payments: -231000.00
NYC cash_flow (quarterly, 2024-12-31) — Common Stock Payments: -231000.00
NYC income_statement (annual, 2024-12-31) — Cost Of Revenue: 41936000.00
NYC balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 0.00
NYC balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 0.00
NYC balance_sheet (annual, 2024-12-31) — Current Assets: 41995000.00
NYC balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 3041000.00
NYC balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 3041000.00
NYC balance_sheet (annual, 2024-12-31) — Current Liabilities: 18343000.00
NYC cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 18408000.00
NYC income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 18408000.00
NYC cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 18408000.00
NYC income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 18408000.00
NYC income_statement (annual, 2024-12-31) — Diluted Average Shares: 2487827.00
NYC income_statement (annual, 2024-12-31) — Diluted EPS: -56.51
NYC income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -140591000.00
NYC balance_sheet (annual, 2024-12-31) — Dueto Related Parties Current: 317000.00
NYC income_statement (annual, 2024-12-31) — EBIT: -121103000.00
NYC income_statement (annual, 2024-12-31) — EBITDA: -102695000.00
NYC cash_flow (annual, 2024-12-31) — End Cash Position: 18935000.00
NYC balance_sheet (annual, 2024-12-31) — Financial Assets: 0.00
NYC balance_sheet (quarterly, 2024-12-31) — Financial Assets: 0.00
NYC cash_flow (annual, 2024-12-31) — Financing Cash Flow: -49731000.00
NYC cash_flow (annual, 2024-12-31) — Free Cash Flow: -5290000.00
NYC cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 276000.00
NYC cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: -1334000.00
NYC cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 276000.00
NYC income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -276000.00
NYC balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
NYC balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
NYC income_statement (annual, 2024-12-31) — General And Administrative Expense: 9624000.00
NYC balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 5875000.00
NYC balance_sheet (annual, 2024-12-31) — Gross PPE: 54514000.00
NYC balance_sheet (quarterly, 2024-12-31) — Gross PPE: 54514000.00
NYC income_statement (annual, 2024-12-31) — Gross Profit: 19634000.00
NYC income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 112541000.00
NYC income_statement (quarterly, 2024-12-31) — Impairment Of Capital Assets: 0.00
NYC cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 0.00
NYC income_statement (annual, 2024-12-31) — Interest Expense: 19488000.00
NYC income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 19488000.00
NYC cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 18467000.00
NYC balance_sheet (annual, 2024-12-31) — Interest Payable: 0.00
NYC balance_sheet (quarterly, 2024-12-31) — Interest Payable: 0.00
NYC balance_sheet (annual, 2024-12-31) — Invested Capital: 432970000.00
NYC cash_flow (annual, 2024-12-31) — Investing Cash Flow: 59857000.00
NYC balance_sheet (annual, 2024-12-31) — Investment Properties: 392884000.00
NYC cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
NYC cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
NYC cash_flow (annual, 2024-12-31) — Issuance Of Debt: 725000.00
NYC balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 55753000.00
NYC balance_sheet (annual, 2024-12-31) — Long Term Debt: 347384000.00
NYC balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 403137000.00
NYC cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 725000.00
NYC cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -50225000.00
NYC cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -50075000.00
NYC balance_sheet (annual, 2024-12-31) — Minority Interest: 0.00
NYC balance_sheet (quarterly, 2024-12-31) — Minority Interest: 0.00
NYC cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -231000.00